FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067931 [Registered on: 27/05/2024] Trial Registered Prospectively
Last Modified On: 15/08/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Primary versus Rotational Flap Closure in Open Neural tube Defects 
Scientific Title of Study   ​​A Randomised Control Study comparing Primary versus Rotational Flap Closure in Pediatric Open Neural Tube Defect Closure 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhalaxmi Nayak 
Designation  Assistant Professor 
Affiliation  Department of Pediatric Surgery, AIIMS Jodhpur  
Address  Department of Pediatric Surgery AIIMS Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  9742022426  
Fax    
Email  drshubhanyk@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shubhalaxmi Nayak 
Designation  Assistant Professor 
Affiliation  Department of Pediatric Surgery, AIIMS Jodhpur  
Address  Room 228, Department of Pediatric Surgery, All India Institute of Medical Sciences Jodhpur,342005, India

Jodhpur
RAJASTHAN
342005
India 
Phone  9742022426  
Fax    
Email  drshubhanyk@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shubhalaxmi Nayak 
Designation  Assistant Professor 
Affiliation  Department of Pediatric Surgery, AIIMS Jodhpur  
Address  Room 228, Department of Pediatric Surgery, All India Institute of Medical Sciences Jodhpur,342005, India

Jodhpur
RAJASTHAN
342005
India 
Phone  9742022426  
Fax    
Email  drshubhanyk@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences Jodhpur 
 
Primary Sponsor  
Name  Dr Shubhalaxmi Nayak 
Address  Room 228, Department of Pediatric Surgery, All India Institute of Medical Sciences Jodhpur,342005, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubhalaxmi Nayak  All India Institute of Medical Sciences Jodhpur  Room 228, Department of Pediatric Surgery, All India Institute of Medical Sciences Jodhpur, 342005,Rajasthan, India
Jodhpur
RAJASTHAN 
9742022426

drshubhanyk@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q059||Spina bifida, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Primary closure   The measurement of skin defect size will be done on OT table after dural closure. Those with defect size more than 5cm will be randomised into two groups for either a primary or a rotational flap closure. 
Intervention  Rotational Flap Closure  The measurement of skin defect size will be done on OT table after dural closure. Those with defect size more than 5cm will be randomised into two groups for either a primary or a rotational flap closure.  
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  3.00 Month(s)
Gender  Both 
Details  Infants under 3 months of age

Diagnosis of open neural tube defect of defect size greater than 5cm longest diameter of skin defect which is measured after dural closure on the OT table

Consent from parents or legal guardians obtained
 
 
ExclusionCriteria 
Details  Patients with ONTDs of over 3 months of age

Patients with closed neural tube defects

Lack of parental or legal guardian consent 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Rates of dehiscence, infection, cerebrospinal fluid leakage, operative duration, the need for a second surgery, length of hospital stay  Assessment at baseline after surgery and at follow up after 1 month, 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Rates of dehiscence, infection, cerebrospinal fluid leakage, operative duration, the need for a second surgery, length of hospital stay  by 1 year of follow up 
 
Target Sample Size   Total Sample Size="88"
Sample Size from India="88" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is anticipated in this randomised control trial, that rotational flap closure will demonstrate comparable or superior outcomes in terms of reduced rates of dehiscence, wound infection, cerebrospinal fluid leakage, and the need for a second surgery when compared to primary closure and this may reduce the morbidity altogether in a one-time procedure with comparable operative duration. Additionally, if rotational flap closure proves to be a viable alternative, a shorter hospital stay is expected for infants undergoing this procedure. The study aims to provide valuable insights into refining the surgical management of open neural tube defects in infants, potentially influencing future clinical practices and improving the overall quality of care for these patients. 
Close